Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of interleukin-12 production (GO:0032695) | 4.17212378 |
2 | neutrophil activation involved in immune response (GO:0002283) | 3.97409007 |
3 | response to peptidoglycan (GO:0032494) | 3.94591100 |
4 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.79488019 |
5 | regulation of chronic inflammatory response (GO:0002676) | 3.75076641 |
6 | immunoglobulin mediated immune response (GO:0016064) | 3.64661523 |
7 | regulation of RIG-I signaling pathway (GO:0039535) | 3.56766172 |
8 | DNA deamination (GO:0045006) | 3.52155966 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.49746414 |
10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47980210 |
11 | modulation by symbiont of host defense response (GO:0052031) | 3.47980210 |
12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47980210 |
13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47980210 |
14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47980210 |
15 | modulation by symbiont of host immune response (GO:0052553) | 3.47980210 |
16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.47146252 |
17 | positive regulation of interleukin-12 production (GO:0032735) | 3.45942118 |
18 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.45723611 |
19 | type I interferon signaling pathway (GO:0060337) | 3.45563745 |
20 | cellular response to type I interferon (GO:0071357) | 3.45563745 |
21 | response to type I interferon (GO:0034340) | 3.42950397 |
22 | telomere maintenance via recombination (GO:0000722) | 3.41717947 |
23 | positive regulation of interferon-alpha production (GO:0032727) | 3.41670865 |
24 | regulation of interleukin-12 production (GO:0032655) | 3.40655111 |
25 | cellular response to interferon-beta (GO:0035458) | 3.36249324 |
26 | tryptophan catabolic process (GO:0006569) | 3.33821071 |
27 | indole-containing compound catabolic process (GO:0042436) | 3.33821071 |
28 | indolalkylamine catabolic process (GO:0046218) | 3.33821071 |
29 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.32841639 |
30 | kynurenine metabolic process (GO:0070189) | 3.32216241 |
31 | negative regulation of T cell mediated immunity (GO:0002710) | 3.25404009 |
32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.23271774 |
33 | negative regulation of cell killing (GO:0031342) | 3.23271774 |
34 | regulation of interferon-alpha production (GO:0032647) | 3.22429297 |
35 | response to muramyl dipeptide (GO:0032495) | 3.21499684 |
36 | T-helper 1 type immune response (GO:0042088) | 3.21495918 |
37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.17390713 |
38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.15633586 |
39 | neutrophil activation (GO:0042119) | 3.15347176 |
40 | macrophage activation involved in immune response (GO:0002281) | 3.12582057 |
41 | regulation of T-helper 1 type immune response (GO:0002825) | 3.11925162 |
42 | mitotic recombination (GO:0006312) | 3.08586547 |
43 | defense response to protozoan (GO:0042832) | 3.07401958 |
44 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.05633645 |
45 | respiratory burst (GO:0045730) | 3.04962977 |
46 | tolerance induction (GO:0002507) | 3.04063710 |
47 | response to interferon-alpha (GO:0035455) | 3.03083556 |
48 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.02690970 |
49 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.02298538 |
50 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01670840 |
51 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.00277388 |
52 | superoxide anion generation (GO:0042554) | 2.99759320 |
53 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.98908130 |
54 | tryptophan metabolic process (GO:0006568) | 2.98832194 |
55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98353818 |
56 | positive regulation of heat generation (GO:0031652) | 2.97980997 |
57 | granulocyte activation (GO:0036230) | 2.97164461 |
58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96759582 |
59 | negative regulation of viral genome replication (GO:0045071) | 2.96704997 |
60 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.95712168 |
61 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.94693606 |
62 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.94468642 |
63 | * regulation of defense response to virus by host (GO:0050691) | 2.93410737 |
64 | mast cell activation (GO:0045576) | 2.93368682 |
65 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.92731338 |
66 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.91995171 |
67 | natural killer cell activation involved in immune response (GO:0002323) | 2.91654077 |
68 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.91521985 |
69 | response to interferon-beta (GO:0035456) | 2.90693253 |
70 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.90626994 |
71 | myeloid dendritic cell activation (GO:0001773) | 2.90321355 |
72 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89745939 |
73 | regulation of T-helper cell differentiation (GO:0045622) | 2.88186541 |
74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87973615 |
75 | DNA strand elongation (GO:0022616) | 2.86263803 |
76 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85937744 |
77 | positive regulation of interferon-gamma production (GO:0032729) | 2.83907806 |
78 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.83672221 |
79 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.83431437 |
80 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83085379 |
81 | regulation of immunoglobulin secretion (GO:0051023) | 2.82894772 |
82 | B cell mediated immunity (GO:0019724) | 2.82847696 |
83 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82758108 |
84 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.82454236 |
85 | cellular response to interleukin-15 (GO:0071350) | 2.81153610 |
86 | response to protozoan (GO:0001562) | 2.80339860 |
87 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.80009397 |
88 | cellular response to interferon-gamma (GO:0071346) | 2.79626772 |
89 | neutrophil mediated immunity (GO:0002446) | 2.78942295 |
90 | NIK/NF-kappaB signaling (GO:0038061) | 2.78625778 |
91 | kinetochore organization (GO:0051383) | 2.78533953 |
92 | interferon-gamma production (GO:0032609) | 2.77715447 |
93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.77250738 |
94 | regulation of interferon-beta production (GO:0032648) | 2.76988376 |
95 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.76467032 |
96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.76467032 |
97 | T cell migration (GO:0072678) | 2.75922364 |
98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75305310 |
99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.75037481 |
100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74978993 |
101 | positive regulation of type 2 immune response (GO:0002830) | 2.74595940 |
102 | lymphocyte chemotaxis (GO:0048247) | 2.74433504 |
103 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.73269831 |
104 | DNA replication initiation (GO:0006270) | 2.73182010 |
105 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.72846000 |
106 | regulation of vitamin metabolic process (GO:0030656) | 2.72213415 |
107 | response to host immune response (GO:0052572) | 2.70243806 |
108 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70243806 |
109 | regulation of antigen processing and presentation (GO:0002577) | 2.70204137 |
110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65062637 |
111 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.64985339 |
112 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.64818510 |
113 | myeloid cell activation involved in immune response (GO:0002275) | 2.63674403 |
114 | dendritic cell chemotaxis (GO:0002407) | 2.63246921 |
115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61838184 |
116 | regulation of mast cell activation (GO:0033003) | 2.61290919 |
117 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.60962562 |
118 | telomere maintenance via telomere lengthening (GO:0010833) | 2.60912230 |
119 | positive regulation of interferon-beta production (GO:0032728) | 2.59747050 |
120 | DNA replication checkpoint (GO:0000076) | 2.59089198 |
121 | kinetochore assembly (GO:0051382) | 2.58822359 |
122 | positive regulation of B cell differentiation (GO:0045579) | 2.57791791 |
123 | DNA strand renaturation (GO:0000733) | 2.56818174 |
124 | CENP-A containing nucleosome assembly (GO:0034080) | 2.54680299 |
125 | positive regulation of interleukin-17 production (GO:0032740) | 2.53522064 |
126 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.53025672 |
127 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.52547731 |
128 | positive regulation of T cell migration (GO:2000406) | 2.51501987 |
129 | negative regulation of growth of symbiont in host (GO:0044130) | 2.51408940 |
130 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.51408940 |
131 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.51408940 |
132 | regulation of growth of symbiont in host (GO:0044126) | 2.51408940 |
133 | leukocyte aggregation (GO:0070486) | 2.51140141 |
134 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.48723603 |
135 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.48708327 |
136 | natural killer cell mediated immunity (GO:0002228) | 2.48708327 |
137 | negative regulation of phagocytosis (GO:0050765) | 2.48500052 |
138 | chromatin remodeling at centromere (GO:0031055) | 2.46035871 |
139 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.45978843 |
140 | * positive regulation of defense response to virus by host (GO:0002230) | 2.45535180 |
141 | leukocyte degranulation (GO:0043299) | 2.44899412 |
142 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.43208678 |
143 | germinal center formation (GO:0002467) | 2.42648893 |
144 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.42593887 |
145 | dendritic cell migration (GO:0036336) | 2.42266167 |
146 | regulation of mast cell degranulation (GO:0043304) | 2.42239271 |
147 | ribosomal small subunit assembly (GO:0000028) | 2.41771093 |
148 | mature B cell differentiation (GO:0002335) | 2.41378257 |
149 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.41348301 |
150 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.41055694 |
151 | meiotic chromosome segregation (GO:0045132) | 2.40532986 |
152 | DNA synthesis involved in DNA repair (GO:0000731) | 2.40310743 |
153 | telomere maintenance (GO:0000723) | 2.40192870 |
154 | myeloid dendritic cell differentiation (GO:0043011) | 2.39549436 |
155 | response to host defenses (GO:0052200) | 2.39081068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.71569055 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.00687338 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.74290942 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.01012949 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.37760948 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.32840248 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.21626965 |
8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.87172582 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83446202 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.81374458 |
11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79701707 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50074910 |
13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.49909272 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.47264191 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44728692 |
16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.44022314 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.43694982 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35149622 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33753067 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29475259 |
21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.24368743 |
22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.21588831 |
23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.20477275 |
24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.05520329 |
25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00216556 |
26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.98130090 |
27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94094832 |
28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.87267988 |
29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.86592013 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 1.79330864 |
31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68401417 |
32 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.68059054 |
33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65705824 |
34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65253732 |
35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65240219 |
36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64010006 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63969575 |
38 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59987883 |
39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59986623 |
40 | MYB_26560356_Chip-Seq_TH1_Human | 1.59891181 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57259487 |
42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51496857 |
43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50813410 |
44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50264830 |
45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.45818644 |
46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45140017 |
47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44858835 |
48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44775847 |
49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44633545 |
50 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44090673 |
51 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.43657068 |
52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41596959 |
53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41293166 |
54 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.41108894 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40408394 |
56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39946744 |
57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39368956 |
58 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38896914 |
59 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36207895 |
60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36164216 |
61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34045178 |
62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31361112 |
63 | MAF_26560356_Chip-Seq_TH1_Human | 1.30711012 |
64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29252584 |
65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29149898 |
66 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25205290 |
67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25099996 |
68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20205931 |
69 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18321169 |
70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16079933 |
71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16013543 |
72 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.15722837 |
73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14952148 |
74 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11359313 |
75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10960578 |
76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10661059 |
77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10368288 |
78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07771896 |
79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06871537 |
80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05461361 |
81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04778172 |
82 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03452836 |
83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01916886 |
84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.00909703 |
85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98957364 |
86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98937064 |
87 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98068142 |
88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97807279 |
89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97661223 |
90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97587877 |
91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97431564 |
92 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97334380 |
93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96613731 |
94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94178217 |
95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93957246 |
96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.93449088 |
97 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93378534 |
98 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.92627208 |
99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92284323 |
100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92109773 |
101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91440277 |
102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91247637 |
103 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.90849003 |
104 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.90471472 |
105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.90471472 |
106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90230459 |
107 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89469130 |
108 | MAF_26560356_Chip-Seq_TH2_Human | 0.89081504 |
109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88850507 |
110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87878285 |
111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87642314 |
112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87519064 |
113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87181415 |
114 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86743092 |
115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85955314 |
116 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85882385 |
117 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84152132 |
118 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.83906873 |
119 | P300_27268052_Chip-Seq_Bcells_Human | 0.83486829 |
120 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83064707 |
121 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.82983368 |
122 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.81470341 |
123 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81038374 |
124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80950336 |
125 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80819217 |
126 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80534617 |
127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80470460 |
128 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.80464245 |
129 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.80162282 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.13785995 |
2 | MP0009785_altered_susceptibility_to | 3.20126722 |
3 | MP0002148_abnormal_hypersensitivity_rea | 3.00417020 |
4 | MP0002396_abnormal_hematopoietic_system | 2.86130016 |
5 | MP0005671_abnormal_response_to | 2.85557947 |
6 | MP0003436_decreased_susceptibility_to | 2.84440229 |
7 | MP0003724_increased_susceptibility_to | 2.72608125 |
8 | MP0005000_abnormal_immune_tolerance | 2.66589456 |
9 | MP0005025_abnormal_response_to | 2.62712232 |
10 | MP0002419_abnormal_innate_immunity | 2.58706231 |
11 | MP0005174_abnormal_tail_pigmentation | 2.56427313 |
12 | MP0010094_abnormal_chromosome_stability | 2.47200079 |
13 | MP0001790_abnormal_immune_system | 2.46668092 |
14 | MP0005387_immune_system_phenotype | 2.46668092 |
15 | MP0002452_abnormal_antigen_presenting | 2.43243095 |
16 | MP0001800_abnormal_humoral_immune | 2.41806427 |
17 | MP0002723_abnormal_immune_serum | 2.37313488 |
18 | MP0008057_abnormal_DNA_replication | 2.34848831 |
19 | MP0001819_abnormal_immune_cell | 2.29216184 |
20 | MP0002420_abnormal_adaptive_immunity | 2.27085104 |
21 | MP0000685_abnormal_immune_system | 2.21405128 |
22 | MP0003763_abnormal_thymus_physiology | 2.18008883 |
23 | MP0003693_abnormal_embryo_hatching | 2.07269334 |
24 | MP0000015_abnormal_ear_pigmentation | 2.05754642 |
25 | MP0002398_abnormal_bone_marrow | 1.99551167 |
26 | MP0005464_abnormal_platelet_physiology | 1.98435030 |
27 | MP0002006_tumorigenesis | 1.87582823 |
28 | MP0006082_CNS_inflammation | 1.86430336 |
29 | MP0008058_abnormal_DNA_repair | 1.84584515 |
30 | MP0000716_abnormal_immune_system | 1.82527226 |
31 | MP0000490_abnormal_crypts_of | 1.82018128 |
32 | MP0004808_abnormal_hematopoietic_stem | 1.80493290 |
33 | MP0001853_heart_inflammation | 1.78079904 |
34 | MP0009333_abnormal_splenocyte_physiolog | 1.78076524 |
35 | MP0003195_calcinosis | 1.77682766 |
36 | MP0002405_respiratory_system_inflammati | 1.75183495 |
37 | MP0003303_peritoneal_inflammation | 1.74974344 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.73650840 |
39 | MP0001545_abnormal_hematopoietic_system | 1.73650840 |
40 | MP0002166_altered_tumor_susceptibility | 1.72131148 |
41 | MP0003806_abnormal_nucleotide_metabolis | 1.70352644 |
42 | MP0003111_abnormal_nucleus_morphology | 1.68977284 |
43 | MP0005075_abnormal_melanosome_morpholog | 1.68397026 |
44 | MP0010155_abnormal_intestine_physiology | 1.65135220 |
45 | MP0008007_abnormal_cellular_replicative | 1.62767633 |
46 | MP0000569_abnormal_digit_pigmentation | 1.58522360 |
47 | MP0003646_muscle_fatigue | 1.57603169 |
48 | MP0002429_abnormal_blood_cell | 1.56047006 |
49 | MP0000689_abnormal_spleen_morphology | 1.55846652 |
50 | MP0004381_abnormal_hair_follicle | 1.52117430 |
51 | MP0002722_abnormal_immune_system | 1.50707444 |
52 | MP0003077_abnormal_cell_cycle | 1.47766801 |
53 | MP0002138_abnormal_hepatobiliary_system | 1.47490110 |
54 | MP0000465_gastrointestinal_hemorrhage | 1.47002937 |
55 | MP0003300_gastrointestinal_ulcer | 1.43387523 |
56 | MP0001845_abnormal_inflammatory_respons | 1.42777404 |
57 | MP0002095_abnormal_skin_pigmentation | 1.42128277 |
58 | MP0001188_hyperpigmentation | 1.40371014 |
59 | MP0005167_abnormal_blood-brain_barrier | 1.38361221 |
60 | MP0001986_abnormal_taste_sensitivity | 1.32453614 |
61 | MP0001533_abnormal_skeleton_physiology | 1.29803858 |
62 | MP0000858_altered_metastatic_potential | 1.29462384 |
63 | MP0000703_abnormal_thymus_morphology | 1.28097196 |
64 | MP0001873_stomach_inflammation | 1.24902592 |
65 | MP0005310_abnormal_salivary_gland | 1.22391295 |
66 | MP0009278_abnormal_bone_marrow | 1.22012616 |
67 | MP0009764_decreased_sensitivity_to | 1.21138864 |
68 | MP0008469_abnormal_protein_level | 1.17618334 |
69 | MP0003448_altered_tumor_morphology | 1.17568428 |
70 | MP0002332_abnormal_exercise_endurance | 1.15314962 |
71 | MP0010307_abnormal_tumor_latency | 1.14357869 |
72 | MP0006292_abnormal_olfactory_placode | 1.13329369 |
73 | MP0002254_reproductive_system_inflammat | 1.13320514 |
74 | MP0003172_abnormal_lysosome_physiology | 1.08620564 |
75 | MP0002277_abnormal_respiratory_mucosa | 1.07239405 |
76 | MP0002019_abnormal_tumor_incidence | 1.06229724 |
77 | MP0005409_darkened_coat_color | 1.06186356 |
78 | MP0004947_skin_inflammation | 1.04904847 |
79 | MP0003075_altered_response_to | 1.02549558 |
80 | MP0003866_abnormal_defecation | 1.00363064 |
81 | MP0009840_abnormal_foam_cell | 1.00123609 |
82 | MP0005058_abnormal_lysosome_morphology | 0.99091288 |
83 | MP0000372_irregular_coat_pigmentation | 0.97592461 |
84 | MP0004782_abnormal_surfactant_physiolog | 0.97534772 |
85 | MP0003136_yellow_coat_color | 0.96706910 |
86 | MP0000343_altered_response_to | 0.96027050 |
87 | MP0008877_abnormal_DNA_methylation | 0.95704676 |
88 | MP0005084_abnormal_gallbladder_morpholo | 0.95574828 |
89 | MP0001663_abnormal_digestive_system | 0.95522400 |
90 | MP0000371_diluted_coat_color | 0.94712099 |
91 | MP0002163_abnormal_gland_morphology | 0.94252461 |
92 | MP0002693_abnormal_pancreas_physiology | 0.91370387 |
93 | MP0002009_preneoplasia | 0.89754670 |
94 | MP0004510_myositis | 0.84164391 |
95 | MP0001501_abnormal_sleep_pattern | 0.83516760 |
96 | MP0002837_dystrophic_cardiac_calcinosis | 0.83324771 |
97 | MP0005164_abnormal_response_to | 0.82871426 |
98 | MP0003183_abnormal_peptide_metabolism | 0.82697403 |
99 | MP0008932_abnormal_embryonic_tissue | 0.82436093 |
100 | MP0003943_abnormal_hepatobiliary_system | 0.82259250 |
101 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82243769 |
102 | MP0000313_abnormal_cell_death | 0.81290706 |
103 | MP0005451_abnormal_body_composition | 0.81223896 |
104 | MP0001851_eye_inflammation | 0.80970729 |
105 | MP0002132_abnormal_respiratory_system | 0.78198098 |
106 | MP0002075_abnormal_coat/hair_pigmentati | 0.77567877 |
107 | MP0004957_abnormal_blastocyst_morpholog | 0.77365018 |
108 | MP0001186_pigmentation_phenotype | 0.76474095 |
109 | MP0002933_joint_inflammation | 0.75913295 |
110 | MP0002998_abnormal_bone_remodeling | 0.75260273 |
111 | MP0001919_abnormal_reproductive_system | 0.75026579 |
112 | MP0009763_increased_sensitivity_to | 0.73549753 |
113 | MP0003950_abnormal_plasma_membrane | 0.72994482 |
114 | MP0000427_abnormal_hair_cycle | 0.72075275 |
115 | MP0003045_fibrosis | 0.71727180 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.71711340 |
117 | MP0008260_abnormal_autophagy | 0.71246209 |
118 | MP0001542_abnormal_bone_strength | 0.70882444 |
119 | MP0002876_abnormal_thyroid_physiology | 0.69501432 |
120 | MP0001119_abnormal_female_reproductive | 0.68331523 |
121 | MP0003656_abnormal_erythrocyte_physiolo | 0.66697562 |
122 | MP0003718_maternal_effect | 0.66519767 |
123 | MP0005166_decreased_susceptibility_to | 0.66435217 |
124 | MP0003786_premature_aging | 0.66393138 |
125 | MP0000604_amyloidosis | 0.66388654 |
126 | MP0005390_skeleton_phenotype | 0.66132462 |
127 | MP0004883_abnormal_blood_vessel | 0.65953434 |
128 | MP0005266_abnormal_metabolism | 0.64751831 |
129 | MP0003828_pulmonary_edema | 0.63740817 |
130 | MP0001764_abnormal_homeostasis | 0.63733120 |
131 | MP0006054_spinal_hemorrhage | 0.63437667 |
132 | MP0005645_abnormal_hypothalamus_physiol | 0.60866648 |
133 | MP0000249_abnormal_blood_vessel | 0.58787501 |
134 | MP0002136_abnormal_kidney_physiology | 0.58071853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.06457562 |
2 | Chromsome breakage (HP:0040012) | 4.75774714 |
3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.73021247 |
4 | Recurrent bacterial skin infections (HP:0005406) | 4.56468624 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.18599534 |
6 | Eczematoid dermatitis (HP:0000976) | 4.14743333 |
7 | Abnormality of T cell number (HP:0011839) | 3.60861706 |
8 | T lymphocytopenia (HP:0005403) | 3.58850255 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 3.54930776 |
10 | Prostate neoplasm (HP:0100787) | 3.52406002 |
11 | Myositis (HP:0100614) | 3.50425913 |
12 | Obstructive lung disease (HP:0006536) | 3.46802722 |
13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.46802722 |
14 | Recurrent fungal infections (HP:0002841) | 3.37811066 |
15 | Keratoconjunctivitis (HP:0001096) | 3.33366166 |
16 | Recurrent viral infections (HP:0004429) | 3.28039651 |
17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.14511566 |
18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.14511566 |
19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.14511566 |
20 | Abnormality of the prostate (HP:0008775) | 3.12099837 |
21 | Recurrent skin infections (HP:0001581) | 3.11017365 |
22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.10303722 |
23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.10303722 |
24 | Abnormality of chromosome stability (HP:0003220) | 3.08694545 |
25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08114160 |
26 | IgM deficiency (HP:0002850) | 3.05768083 |
27 | Clubbing of toes (HP:0100760) | 3.05698639 |
28 | Optic neuritis (HP:0100653) | 3.03620842 |
29 | Retrobulbar optic neuritis (HP:0100654) | 3.03620842 |
30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95286559 |
31 | Thrombocytosis (HP:0001894) | 2.93232771 |
32 | Chronic otitis media (HP:0000389) | 2.93068950 |
33 | Basal ganglia calcification (HP:0002135) | 2.90999566 |
34 | Meningitis (HP:0001287) | 2.90000815 |
35 | Reticulocytopenia (HP:0001896) | 2.89545171 |
36 | Abnormality of macrophages (HP:0004311) | 2.81879671 |
37 | Petechiae (HP:0000967) | 2.74865154 |
38 | Abnormality of T cell physiology (HP:0011840) | 2.73842971 |
39 | Orchitis (HP:0100796) | 2.73554990 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.72930920 |
41 | Birth length less than 3rd percentile (HP:0003561) | 2.72448313 |
42 | Aplastic anemia (HP:0001915) | 2.72213733 |
43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71855431 |
44 | Congenital stationary night blindness (HP:0007642) | 2.65899263 |
45 | Abnormality of the preputium (HP:0100587) | 2.65861556 |
46 | Duplicated collecting system (HP:0000081) | 2.65617513 |
47 | Vasculitis (HP:0002633) | 2.65576354 |
48 | Increased cerebral lipofuscin (HP:0011813) | 2.64480947 |
49 | Reduced antithrombin III activity (HP:0001976) | 2.63537239 |
50 | Abnormality of the renal collecting system (HP:0004742) | 2.60914783 |
51 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.59279080 |
52 | Abnormality of DNA repair (HP:0003254) | 2.55444513 |
53 | Stomatitis (HP:0010280) | 2.53975910 |
54 | Gangrene (HP:0100758) | 2.53880096 |
55 | Increased IgM level (HP:0003496) | 2.52636398 |
56 | Panhypogammaglobulinemia (HP:0003139) | 2.51088636 |
57 | Gingivitis (HP:0000230) | 2.45266052 |
58 | Gastrointestinal infarctions (HP:0005244) | 2.45082344 |
59 | Meckel diverticulum (HP:0002245) | 2.44914642 |
60 | Stomach cancer (HP:0012126) | 2.42471362 |
61 | Myelodysplasia (HP:0002863) | 2.40037762 |
62 | Acute myeloid leukemia (HP:0004808) | 2.39192933 |
63 | IgG deficiency (HP:0004315) | 2.37676446 |
64 | Bone marrow hypocellularity (HP:0005528) | 2.37326442 |
65 | Abnormality of T cells (HP:0002843) | 2.36436216 |
66 | Recurrent pneumonia (HP:0006532) | 2.36134485 |
67 | Abnormality of the ileum (HP:0001549) | 2.35216893 |
68 | Periodontitis (HP:0000704) | 2.35097015 |
69 | Abnormality of the pleura (HP:0002103) | 2.33025468 |
70 | Type I transferrin isoform profile (HP:0003642) | 2.31519602 |
71 | Pancreatic cysts (HP:0001737) | 2.31292443 |
72 | Anorexia (HP:0002039) | 2.29263496 |
73 | Pustule (HP:0200039) | 2.27633115 |
74 | Prolonged bleeding time (HP:0003010) | 2.26946153 |
75 | Encephalitis (HP:0002383) | 2.26361543 |
76 | Vacuolated lymphocytes (HP:0001922) | 2.26043547 |
77 | Combined immunodeficiency (HP:0005387) | 2.25919927 |
78 | Leukocytosis (HP:0001974) | 2.25439761 |
79 | Lymphoma (HP:0002665) | 2.25413062 |
80 | Hypergammaglobulinemia (HP:0010702) | 2.24075530 |
81 | Granulocytopenia (HP:0001913) | 2.24075394 |
82 | Arterial thrombosis (HP:0004420) | 2.23688824 |
83 | Recurrent lower respiratory tract infections (HP:0002783) | 2.23241395 |
84 | Pulmonary infiltrates (HP:0002113) | 2.23166591 |
85 | Abolished electroretinogram (ERG) (HP:0000550) | 2.22511193 |
86 | Eosinophilia (HP:0001880) | 2.20763858 |
87 | Molar tooth sign on MRI (HP:0002419) | 2.16726530 |
88 | Abnormality of midbrain morphology (HP:0002418) | 2.16726530 |
89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12150191 |
90 | Recurrent bronchitis (HP:0002837) | 2.11472519 |
91 | Ectopic kidney (HP:0000086) | 2.11382674 |
92 | Parakeratosis (HP:0001036) | 2.09005891 |
93 | Pallor (HP:0000980) | 2.07459996 |
94 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.06724691 |
95 | Keratitis (HP:0000491) | 2.06445709 |
96 | Cellulitis (HP:0100658) | 2.06376083 |
97 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04383471 |
98 | Abnormality of the pericardium (HP:0001697) | 2.03742147 |
99 | Polyneuropathy (HP:0001271) | 2.03559926 |
100 | Papilledema (HP:0001085) | 2.03426597 |
101 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02461833 |
102 | Pancytopenia (HP:0001876) | 2.02338336 |
103 | Pulmonary fibrosis (HP:0002206) | 2.01517397 |
104 | IgA deficiency (HP:0002720) | 2.00020916 |
105 | Attenuation of retinal blood vessels (HP:0007843) | 1.98000335 |
106 | 3-Methylglutaconic aciduria (HP:0003535) | 1.97988841 |
107 | Abnormality of eosinophils (HP:0001879) | 1.97444723 |
108 | Chronic diarrhea (HP:0002028) | 1.96022482 |
109 | Agammaglobulinemia (HP:0004432) | 1.95558607 |
110 | Agnosia (HP:0010524) | 1.95104752 |
111 | Autoimmune hemolytic anemia (HP:0001890) | 1.94985569 |
112 | Hemoptysis (HP:0002105) | 1.94217934 |
113 | Type II lissencephaly (HP:0007260) | 1.93890444 |
114 | Keratoconjunctivitis sicca (HP:0001097) | 1.93479702 |
115 | Abnormal number of erythroid precursors (HP:0012131) | 1.93209946 |
116 | Abnormality of the fingertips (HP:0001211) | 1.92005611 |
117 | Abnormality of the pons (HP:0007361) | 1.91902490 |
118 | Leukopenia (HP:0001882) | 1.91380832 |
119 | Gingival bleeding (HP:0000225) | 1.91151978 |
120 | Osteomyelitis (HP:0002754) | 1.90422743 |
121 | Epistaxis (HP:0000421) | 1.89975189 |
122 | Albinism (HP:0001022) | 1.89172532 |
123 | Urticaria (HP:0001025) | 1.88930662 |
124 | Hematochezia (HP:0002573) | 1.88267155 |
125 | Bronchitis (HP:0012387) | 1.88042648 |
126 | Neutropenia (HP:0001875) | 1.87586904 |
127 | Poor head control (HP:0002421) | 1.87106162 |
128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86030840 |
129 | Lymphopenia (HP:0001888) | 1.85679004 |
130 | Cheilitis (HP:0100825) | 1.85238923 |
131 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84756771 |
132 | Hypoplasia of the pons (HP:0012110) | 1.84592667 |
133 | Severe combined immunodeficiency (HP:0004430) | 1.84002424 |
134 | Exertional dyspnea (HP:0002875) | 1.83494077 |
135 | Abnormality of the columella (HP:0009929) | 1.83116950 |
136 | B lymphocytopenia (HP:0010976) | 1.82755360 |
137 | Abnormality of B cell number (HP:0010975) | 1.82755360 |
138 | Chronic sinusitis (HP:0011109) | 1.82529937 |
139 | Thyroiditis (HP:0100646) | 1.81601984 |
140 | Inflammation of the large intestine (HP:0002037) | 1.80541157 |
141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78585432 |
142 | Abnormality of alanine metabolism (HP:0010916) | 1.78585432 |
143 | Hyperalaninemia (HP:0003348) | 1.78585432 |
144 | Episodic fever (HP:0001954) | 1.78132827 |
145 | Alveolar cell carcinoma (HP:0006519) | 1.77928241 |
146 | Gastrointestinal stroma tumor (HP:0100723) | 1.74046836 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK4 | 4.22222879 |
2 | MAP3K14 | 3.51475430 |
3 | IRAK3 | 3.10122116 |
4 | FRK | 2.93765481 |
5 | TXK | 2.58872963 |
6 | BLK | 2.50718646 |
7 | CLK1 | 2.44228256 |
8 | MAP4K1 | 2.34083065 |
9 | TAOK3 | 2.33735867 |
10 | KIT | 2.25071401 |
11 | TEC | 2.11926273 |
12 | IKBKE | 1.99209057 |
13 | PIM2 | 1.97714880 |
14 | CDC7 | 1.97281439 |
15 | TYK2 | 1.95528755 |
16 | TBK1 | 1.85775948 |
17 | JAK3 | 1.83169122 |
18 | NME2 | 1.82439487 |
19 | VRK1 | 1.80244201 |
20 | PLK4 | 1.78915849 |
21 | IKBKB | 1.75347034 |
22 | BTK | 1.67715682 |
23 | EIF2AK2 | 1.56221669 |
24 | BMPR2 | 1.45802636 |
25 | CAMKK2 | 1.44712024 |
26 | RIPK4 | 1.42864837 |
27 | MKNK2 | 1.42352549 |
28 | ZAK | 1.41489294 |
29 | ZAP70 | 1.38914857 |
30 | ACVR1B | 1.37525881 |
31 | STK16 | 1.36657178 |
32 | PIM1 | 1.35579650 |
33 | FES | 1.32044460 |
34 | MKNK1 | 1.30035218 |
35 | SYK | 1.27454858 |
36 | SRPK1 | 1.25234907 |
37 | MAP3K6 | 1.22662456 |
38 | WEE1 | 1.22576295 |
39 | TLK1 | 1.21505271 |
40 | IRAK1 | 1.19616964 |
41 | ATR | 1.19164952 |
42 | MARK3 | 1.15647119 |
43 | MAP3K13 | 1.15021515 |
44 | NLK | 1.14976480 |
45 | BMPR1B | 1.11860862 |
46 | EIF2AK1 | 1.11726052 |
47 | LYN | 1.10334963 |
48 | CHUK | 1.10298694 |
49 | MAP4K2 | 1.08035324 |
50 | CSF1R | 1.07828558 |
51 | YES1 | 1.07426636 |
52 | JAK1 | 1.06825826 |
53 | TRPM7 | 1.05065471 |
54 | TNIK | 1.03061931 |
55 | NEK9 | 1.02693969 |
56 | STK4 | 1.01599348 |
57 | MAP2K3 | 1.01383489 |
58 | LCK | 1.00212041 |
59 | TTK | 0.99213960 |
60 | ADRBK2 | 0.94336293 |
61 | CDK8 | 0.93309450 |
62 | HCK | 0.88212306 |
63 | PRKCQ | 0.87701308 |
64 | IRAK2 | 0.86265700 |
65 | RPS6KA4 | 0.85373700 |
66 | CSK | 0.83405089 |
67 | PBK | 0.82268063 |
68 | DAPK2 | 0.80981867 |
69 | MAP2K6 | 0.80929602 |
70 | STK10 | 0.80740347 |
71 | GRK6 | 0.78814555 |
72 | SIK2 | 0.78684942 |
73 | EIF2AK3 | 0.77438749 |
74 | BRSK2 | 0.77194021 |
75 | MAP3K11 | 0.77043557 |
76 | TAOK2 | 0.76017385 |
77 | CDK7 | 0.75718421 |
78 | CASK | 0.75115022 |
79 | CCNB1 | 0.68017114 |
80 | BUB1 | 0.67977620 |
81 | ADRBK1 | 0.67566813 |
82 | GRK1 | 0.62733284 |
83 | MAPKAPK3 | 0.62028853 |
84 | WNK4 | 0.61230138 |
85 | TGFBR1 | 0.61104731 |
86 | FGR | 0.60957071 |
87 | GRK7 | 0.60821221 |
88 | RPS6KA5 | 0.60502064 |
89 | AURKB | 0.60297412 |
90 | ITK | 0.59819296 |
91 | PLK1 | 0.59445755 |
92 | MATK | 0.58970070 |
93 | RPS6KA6 | 0.58463788 |
94 | TSSK6 | 0.57208936 |
95 | NEK2 | 0.56884538 |
96 | OXSR1 | 0.55828312 |
97 | MAP2K2 | 0.55451431 |
98 | MAPKAPK5 | 0.55257596 |
99 | MST4 | 0.54399552 |
100 | MAPK11 | 0.53250280 |
101 | DYRK3 | 0.52813108 |
102 | FLT3 | 0.52617807 |
103 | CDK4 | 0.52528775 |
104 | VRK2 | 0.51835564 |
105 | TAF1 | 0.51128360 |
106 | TAOK1 | 0.51116608 |
107 | MOS | 0.50947566 |
108 | INSRR | 0.50839724 |
109 | PKN1 | 0.49749550 |
110 | MAP3K3 | 0.48692193 |
111 | MAP3K5 | 0.48057436 |
112 | NUAK1 | 0.46772453 |
113 | SIK3 | 0.43996922 |
114 | MELK | 0.43420239 |
115 | TNK2 | 0.42912180 |
116 | PRKD2 | 0.42191625 |
117 | CHEK2 | 0.41764546 |
118 | ATM | 0.41549791 |
119 | MUSK | 0.40659164 |
120 | ABL1 | 0.39787990 |
121 | STK11 | 0.38688856 |
122 | PDK1 | 0.37570612 |
123 | TESK2 | 0.37497842 |
124 | EPHA3 | 0.37002452 |
125 | MAPKAPK2 | 0.36784909 |
126 | JAK2 | 0.36636230 |
127 | TGFBR2 | 0.35058019 |
128 | HIPK2 | 0.33960624 |
129 | CDK3 | 0.33722827 |
130 | CSNK2A1 | 0.33518012 |
131 | MAPK15 | 0.32148286 |
132 | PIK3CG | 0.31711955 |
133 | PTK2B | 0.28062403 |
134 | PINK1 | 0.27715078 |
135 | PRKCD | 0.26964497 |
136 | IGF1R | 0.26065259 |
137 | CDC42BPA | 0.26052100 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.35124649 |
2 | Homologous recombination_Homo sapiens_hsa03440 | 2.88196431 |
3 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.70738120 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 2.51271636 |
5 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.22636289 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.19662347 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18865706 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.15799841 |
9 | Measles_Homo sapiens_hsa05162 | 2.11636921 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10350416 |
11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.03596380 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00809439 |
13 | Base excision repair_Homo sapiens_hsa03410 | 1.94377987 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91381622 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87633924 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.83557017 |
17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.80176310 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79760688 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73885285 |
20 | Asthma_Homo sapiens_hsa05310 | 1.63380041 |
21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.59248794 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.59059538 |
23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53485921 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.50342901 |
25 | Ribosome_Homo sapiens_hsa03010 | 1.49129868 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.48081489 |
27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45911729 |
28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42084305 |
29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.41250052 |
30 | Cell cycle_Homo sapiens_hsa04110 | 1.37113770 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35931238 |
32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35067243 |
33 | Malaria_Homo sapiens_hsa05144 | 1.34709572 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31233947 |
35 | RNA polymerase_Homo sapiens_hsa03020 | 1.29932423 |
36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.27340293 |
37 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21977051 |
38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20232904 |
39 | Spliceosome_Homo sapiens_hsa03040 | 1.19590539 |
40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18146585 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.16472710 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15966847 |
43 | RNA degradation_Homo sapiens_hsa03018 | 1.15636003 |
44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14926442 |
45 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12997322 |
46 | Hepatitis B_Homo sapiens_hsa05161 | 1.07256813 |
47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06215348 |
48 | Apoptosis_Homo sapiens_hsa04210 | 1.02090382 |
49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01524991 |
50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99988543 |
51 | Shigellosis_Homo sapiens_hsa05131 | 0.99864871 |
52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99770589 |
53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99676034 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96731978 |
55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93418906 |
56 | Salmonella infection_Homo sapiens_hsa05132 | 0.92696487 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90369050 |
58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88572728 |
59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88304049 |
60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86395452 |
61 | Proteasome_Homo sapiens_hsa03050 | 0.85864112 |
62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84040748 |
63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83381713 |
64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82108195 |
65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81532149 |
66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80751786 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76091283 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.75448062 |
69 | Protein export_Homo sapiens_hsa03060 | 0.75308331 |
70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71535848 |
71 | Purine metabolism_Homo sapiens_hsa00230 | 0.70014344 |
72 | RNA transport_Homo sapiens_hsa03013 | 0.69380607 |
73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69378776 |
74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68887174 |
75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66873196 |
76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66518759 |
77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65751216 |
78 | Phagosome_Homo sapiens_hsa04145 | 0.65748224 |
79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65267144 |
80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64120011 |
81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63064718 |
82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60859961 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60079067 |
84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59879967 |
85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59115934 |
86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58825414 |
87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57843492 |
88 | Phototransduction_Homo sapiens_hsa04744 | 0.57823765 |
89 | Lysosome_Homo sapiens_hsa04142 | 0.56168714 |
90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55488236 |
91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55232802 |
92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54185048 |
93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54064094 |
94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53393042 |
95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52886992 |
96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52877073 |
97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50827238 |
98 | Platelet activation_Homo sapiens_hsa04611 | 0.49102278 |
99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47331401 |
100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45786783 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45420322 |
102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44467589 |
103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43066600 |
104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42594436 |
105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42347644 |
106 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41390487 |
107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40976815 |
108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40364909 |
109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40173359 |
110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39826155 |
111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39771318 |
112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37476232 |
113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36675527 |
114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35970914 |
115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32994028 |
116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30235346 |
117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29279688 |
118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28045383 |
119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27731262 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27376975 |
121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27173644 |
122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23532990 |
123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19834099 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19174478 |
125 | Mineral absorption_Homo sapiens_hsa04978 | 0.15741364 |
126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14475957 |